Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Death_Metalon Sep 13, 2018 8:01am
139 Views
Post# 28610545

RE:RE:RE:RE:Interesting article...on C.HUGE.....beware !

RE:RE:RE:RE:Interesting article...on C.HUGE.....beware !
bionicjoe wrote: Most institutions are holding back to see how the cannabis sector unfolds but if or when they start piling in then look out. I think 2019 should start to give us some clarity on who the front runners will be. Like any sector not all will make it. It's no different for the retail investor in that they have to try and pick the winners. I didn't invest in WEED when it was $27 because I thought it too expensive. Then when it dropped from a then high to $34 bucks I thought I'd wait to $33 and then jump in. Now it's $66 and I have to live with squandered opportunity. You can't always think micro caps if you want to make money. They are historical micro caps for a reason. Not saying not to invest in TLT but I would question making it the only core holding in your portfolio when it could take years to resolve its science.


I get it BioJoe...
Thanks 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities